Oncology Cancer patients don’t care where the breakthrough happened. ... National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.
News FDA prior knowledge guide seeks to speed cell, gene therapy The FDA has laid out a framework to use 'prior knowledge' on manufacturing, non-clinical, and clinical data to support cell and gene therapy filings.
Market Access Approval designed from day one: Building global-ready regula... The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.
News November date set for FDA decision on Sanofi's Gaucher drug The FDA has started a priority review of Sanofi's brain-acting Gaucher disease therapy venglustat, with an action date of 25th November.
News FDA delays verdict on AZ breast cancer drug After an advisory committee setback, AstraZeneca has a chance to make the case for its oral SERD camizestrant for breast cancer.
News Oral Wegovy backed by CHMP at May meeting The CHMP recommended eight new medicines and 13 line extensions at its May meeting, including Novo Nordisk's oral weight loss therapy.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.